The landscape of dementia diagnosis has developed substantially with the arrival of subtle biomarkers, together with amyloid PET scans, tau imaging, and blood-based tests that can detect Alzheimer's pathology many years before symptoms arise. While these technological improvements characterize remarkable progress in comprehension neurodegenerative